San Francisco, California
London, United Kingdom
Invitation for the 3rd Annual CPI Symposium
9:00 am - 5:00 pm, June 7th, 2017
Please mark your calendars for the 3rd annual CPI symposium, which will be held in Sherrington lecture theatre on June 7th, 2017. This year's Key Note speaker is Dr Po-Wah So from King's College London. There will be a four sessions covering the Pre-clinical Imaging applications in (a) Cancer, (b) Kidney, (c) Liver and (d) Neuro imaging. There will be another special session covering the (e) Novel applications and contrast mechanisms in CPI.
If you are interested, please register for the event with a suitable ticket. Following are your ticket options:
1. Attendee - if you are just attending as an audience
2. Presenter for Invited Talk (Student/Faculty/CPI Researcher) - if you are presenting as an "invited speaker" in the symposium. An "invited speaker" could either be a graduate student, post-doctoral researcher, researcher working in CPI, or a faculty
3. Presenter (Key Note Speaker) - if you are presenting as a "key-note invited speaker" in the symposium
4. Industrial Sponsor - if you are an industrial sponsor who have paid for the setup of a desk
We look forward to see you on 7th of June!
Save This Event
When & Where
Dr Poptani is a Professor and Chair of the center for Preclinical Imaging at the University of Liverpool, UK, After completing his PhD from India, he did his fist postdoc in Kuopio, Finland with Dr Risto Kauppinen and his second postdoc with Dr Jerry Glickson at the University of Pennsylvania, USA, where he continued his academic career for another 15 years before he moved to the University of Liverpool in December 2014. Dr Poptani’s publications include over 105 peer reviewed papers, book chapters and review articles. His research focus is on development and application of advanced magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) methods, with specific applications in neuroimaging and cancer. His group was among the first to demonstrate the utility of diffusion weighted imaging and spectroscopy to assess response to gene therapy for brain tumors and for detection of apoptotic cell death in vivo. His group has also been credited for developing small animal neuroimaging methods at the University of Pennsylvania including high-throughput methods for MR microscopy, stem cell tracking as well as diffusion tensor imaging for isolated tissues. These methods were later adapted for in vivo applications of the mouse as well as the rat brain and have been applied to study mouse models of memory disorders, schizophrenia and autism. In addition, Dr Poptani’s research group has been developing high resolution 1D and 2D MR spectroscopy techniques in preclinical models. With a strong interest in translational studies, Dr Poptani’s group has continued to be involved in clinical MRI and MRS research and has implemented several cutting edge spectroscopic techniques on clinical magnets. Some of these methods include high resolution whole brain 3D MRS on 3T, single voxel 2D L-COSY on the human 7T magnet and several image processing algorithms for processing diffusion tensor imaging and dynamic contrast enhanced imaging data.
Atul Singh Minhas
Dr Minhas is a Centre Manager of the Centre for Preclinical Imaging at the University of Liverpool, UK. After completing his PhD in February 2011 from Kyung Hee University (KHU) in South Korea, he joined as a postdoc in KHU. But within the four months of his postdoc, Dr Minhas was scouted by Samsung Electronics in Korea to join their newly established MRI development team. Dr Minhas worked there for 4.5 years before joining the University of Liverpool in January 2016. At Samsung, he obtained a rare experience of building an MRI system from concept to a fully functional imaging device. Dr Minhas has expertise in the MRI gradient/shim coil design, and MRI pulse sequence programming. During his PhD, Dr Minhas worked on a novel application of magnetic resonance imaging (MRI) where electrical conductivity of body tissues is measured using MR phase images. He published several papers in this research domain and attended multiple conferences across the world. He is interested in extending this technology to mice liver and kidney imaging for the safety and efficacy evaluation of regenerative medicine therapies. His current focus is on development of novel contrast mechanisms for MRI with specific research focus on chemical exchange saturation transfer (CEST) and electrical conductivity based contrast mechanisms.